Preliminary scientific studies suggest conolidine may inhibit certain ion channels, reducing neuronal excitability and limiting discomfort signals. This system is especially appropriate in neuropathic agony, exactly where abnormal signaling leads to persistent soreness. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pa